ConductScience.org, home

Paper40985161

Luminescent Nanocucurbits Enable Spatiotemporal Co-Delivery of Hydrophilic and Hydrophobic Chemotherapeutic Agents.

Wei P and 4 others. Adv Sci (Weinh), 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Luminescent Nanocucurbits Enable Spatiotemporal Co-Delivery of Hydrophilic and Hydrophobic Chemotherapeutic Agents. Papers, record 40985161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40985161

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Luminescent Nanocucurbits Enable Spatiotemporal Co-Delivery of Hydrophilic and Hydrophobic Chemotherapeutic Agents.
PubMed
Journal
Adv Sci (Weinh)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-12-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wei PPinghttps://orcid.org/0000-0003-3867-0141
2Ding YYunshan
3Liu SShangning
4Jiang JJinhui
5Chen JJinghua

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Delivery SystemsMajor topic
Antineoplastic AgentsMajor topic
NanoparticlesMajor topic
NanostructuresMajor topic
Hydrophobic and Hydrophilic Interactions
Humans
Doxorubicin
Cell Line, Tumor
Drug Carriers

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
22305102National Natural Science Foundation of ChinaPubMed
BK20221097Basic Research Program of JiangsuPubMed
KLCCB-KF202405Open Project of Key Laboratory of Carbohydrate Chemistry and Biotechnology (Jiangnan University), Ministry of EducationPubMed

Source PubMed

Download CSV of grants

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134175367Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant.J Control Release2021https://conductscience.org/library/papers/34175367PubMed
233609621Polymeric micelles in cancer therapy: State of the art.J Control Release2021https://conductscience.org/library/papers/33609621PubMed
339698747Biodegradable Nanobowls with Controlled Dents.ACS Macro Lett2025https://conductscience.org/library/papers/39698747PubMed
435931466Multicompartmental Microcapsules for Enzymatic Cascade Reactions Prepared through Gas Shearing and Surface Gelation.Biomacromolecules2022https://conductscience.org/library/papers/35931466PubMed
533500737Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.Theranostics2021https://conductscience.org/library/papers/33500737PubMed
634607478Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of in vivo lung cancer animal model.Drug Deliv2021https://conductscience.org/library/papers/34607478PubMed
732316537Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell.Pharmaceutics2020https://conductscience.org/library/papers/32316537PubMed
838604384Co-encapsulation of granzyme B and perforin in nanocapsules for tumour therapy: biomimicking immune cells.J Control Release2024https://conductscience.org/library/papers/38604384PubMed
938615388Dendritic polymer prodrug-based unimolecular micelles for pH-responsive co-delivery of doxorubicin and camptothecin with synergistic controlled drug release effect.Colloids Surf B Biointerfaces2024https://conductscience.org/library/papers/38615388PubMed
1035820601Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.Adv Drug Deliv Rev2022https://conductscience.org/library/papers/35820601PubMed
1139688563A Polypeptosome Spray To Heal Antibiotic-Resistant Bacteria-Infected Wound by Photocatalysis-Induced Metabolism-Interference.ACS Nano2024https://conductscience.org/library/papers/39688563PubMed
1233527954Short intrinsically disordered polypeptide-oligonucleotide conjugates for programmed self-assembly of nanospheres with temperature-dependent size controllability.Soft Matter2021https://conductscience.org/library/papers/33527954PubMed
1326529199Co-delivery of drugs and plasmid DNA for cancer therapy.Adv Drug Deliv Rev2016https://conductscience.org/library/papers/26529199PubMed
1424818887Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.Biomaterials2014https://conductscience.org/library/papers/24818887PubMed
1538309054Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapy.Biomaterials2024https://conductscience.org/library/papers/38309054PubMed
1640264332Preparation and Mechanism Insight of Biodegradable Kippah Vesicles.Small2025https://conductscience.org/library/papers/40264332PubMed
1724875756Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugs.Biomaterials2014https://conductscience.org/library/papers/24875756PubMed
1825542535In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.Acta Biomater2015https://conductscience.org/library/papers/25542535PubMed
1938906204Improving hemocompatibility in tissue-engineered products employing heparin-loaded nanoplatforms.Pharmacol Res2024https://conductscience.org/library/papers/38906204PubMed
2017312383The activity of caspases in spontaneous and camptothecin-induced death of melanotic and amelanotic melanoma cell.Cancer Biol Ther2007https://conductscience.org/library/papers/17312383PubMed

See all 57 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41754938Smart Nanoformulations for Oncology: A Review on Overcoming Biological Barriers with Active Targeting, Stimuli-Responsive, and Controlled Release for Effective Drug Delivery.Pharmaceutics2026https://conductscience.org/library/papers/41754938PubMed
40985161Luminescent Nanocucurbits Enable Spatiotemporal Co-Delivery of Hydrophilic and Hydrophobic Chemotherapeutic Agents.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40985161PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40985161

GET https://conductscience.org/api/papers/v1/40985161/references?page=2